The 20th Annual AVCJ China Forum 2021 | AVCJ An Acuris Company | 12 October 2021 | China World Summit Wing Beijing, 1 Jianguomen Outer St, Jian Wai Da Jie, Chaoyang, Beijing, China, 100004

The pioneer China-focused international private equity and venture capital event, the AVCJ China Forum, has remained unrivalled as the most influential gathering of domestic Chinese and international institutional investors, fund managers and professional advisors since its inception in 2001.

From an intimate gathering of like-minded professionals to the much-anticipated event it is today, the AVCJ China Forum has grown with the local market to welcome more than 520 delegates including 245 institutional investors who are keen on the China-related opportunities.

This year, the forum will celebrate 20 years in the market with a thorough program that combines editorially-driven topics, high-level speakers, deep industry knowledge and superb organization into a highly anticipated event that predicts trends, create strategies and forges lasting partnerships in China and beyond.

NEW Highlights of this year’s forum include:
• Private markets outlook: Navigating a new era
• 20 years of private equity in China: Past, present, and future
• Deep dive into deep tech investing
• In pursuit of alpha: Lessons in value creation
• LP expectations: Capturing growth and returns in China
• Capital market reforms and the future of exits in China

2021 Speakers

KEYNOTE SPEAKERS:

Bao Fan
Chairman & CEO, China Renaissance Group

Yibing Wu
Head of China and Joint Head of Enterprise Development Group, Temasek

SPEAKERS:

Victor Ai
Founder and CEO, Terminus Group

Kurt Björklund
Managing Partner, Permira

Daisy Cai
General Partner and Head of China, B Capital Group

Elwin Chai
Senior Director, CDPQ

Michael Chen
Managing Director, Centurium Capital

Jacob Chiu
Managing Director, HQ Capital

Effie Dai
Partner, Deal Strategy, KPMG

Alex Emery
Partner, Head of Asia, Permira

Doris Guo
Partner, Adams Street Partners

James Huang
Founding Managing Partner, Panacea Venture

Mingming Huang
Founding Partner, Future Capital Discovery Fund

Priscilla Huang
Partner, KPMG

James Ieong
Founder and Managing Partner, Pagoda Capital

Xing Ji
Managing Director, Managing Partner of Lighthouse Growth Fund, Lighthouse Capital

Ethan Jin
Partner, Cooley Llp

Frank Jin
Executive Director, Asia-Pacific Mergers & Acquisitions, Morgan Stanley

Yup S. Kim
Investment Director and Head of Investments, Calpers Private Equity

Eva Lee
Head of Hong Kong Equities, UBS Global Wealth Management Chief Investment Office

John C. Lee
Vice Chairman and Head of Greater China, Global Banking, UBS

Qingru Li
Director, Allianz Capital Partners

Richard Li
President/Managing Director, Legend Capital

Zidi Liu
Founding Partner, Green Harbor Investment

Sean Lu
Managing Director, Head of MedTech and Medical Services, CBC Group

Yipin Ng
Managing Partner, Yunqi Partners

Sally Shan
Managing Director, Harbourvest Partners

Adam Shen
Vice President, Corporate Development, Head of M&A Asia, Member of DHR China Board, Danaher Corporation

Weichou Su
Partner and Head of Asia, Stepstone Group

Jialin Sun
CEO, GTJA Investment Group

Simon Sun
Partner, Bain & Company

Jui Tan
Managing Partner, Bluerun Ventures China

Jeffery Tang
President, United Value Capital

Daizong Wang
Partner, Newquest Capital Partners

Oscar Wang
Director of APAC Business Development, Incloudcounsel

Ou Wang
Member of the Management and Decision Committee, China Everbright Ltd.

Steven Wang
Founder & CEO, Highlight Capital

Gian-Marc Widmer
Director and Head of International M&A, Citic Securities Co., LTD.

Lawrence Xia
Executive Director, CDH

Anna Xu
Founding Partner, Hike Capital

Jingyi Xu
Partner, Cooley Llp

Jeacy Yan
Founding Partner, Being Capital

Yi Yang
Founding Managing Partner, Jinyi Capital

Zhan Yang
Investment Principal, Coller Capital

Xun Zeng
Partner, Cooley LLP

Alex Zhang
Founding Partner, Hosen Capital

Jinjian Zhang
Founding Partner, Vitalbridge

Sarah Zhang
Vice President, Global Issuer Services, HKEX

Lane Zhao
Founder & Chief Executive Officer, Innovision Capital

Jielun Zhu
Chief Financial Officer, I-Mab Biopharma Co. LTD

2021 Sponsors

LEAD SPONSOR:
• Permira

ASIA SERIES SPONSOR:
• KMPG

CO-SPONSORS:
• Adams Street
• B Capital Group
• Being Capital
• CDH
• Centurium Capital
• China Renaissance
• Coller Capital
• Future Capital
• GreenHarbor
• GTJA Investment Group
• Highlight Capital
• Hike Capital
• InCloudCounsel
• Inno Vision Capital
• Jinyi Capital
• LightHouse
• New Quest Capital Partners
• Strat Op
• Terminus
• United Value Capital
• Vitalbridge

VC LEGAL SPONSOR:
• Cooley